Do we really need long‐term hepatitis B hyperimmune globulin? What are the alternatives? | Zendy

Lake John R. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Do we really need long‐term hepatitis B hyperimmune globulin? What are the alternatives?

Author(s) -

Lake John R.

Publication year - 2008

Publication title -

liver transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.814

H-Index - 150

eISSN - 1527-6473

pISSN - 1527-6465

DOI - 10.1002/lt.21637

Subject(s) - medicine , liver transplantation , hepatitis b immune globulin , hepatitis b , antiviral treatment , immunology , virology , hepatitis b virus , chronic hepatitis , transplantation , intensive care medicine , hbsag , virus

Key Points1 The outcomes of liver transplantation for patients with hepatitis are the best for any diagnosis. 2 Prevention of HBV re‐infection is the key to excellent outcomes after liver transplantation. 3 The use of hepatitis B immunoglobulin to prevent HBV re‐infection is effective, but costly and with side effects. 4 Effective prophylaxis against HBV re‐infection can now be accomplished with combination nucleoside/nucleotide anti‐virals.Liver Transpl 14:S23–S26, 2008. © 2008 AASLD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research